Supplementary Material from In silico simulation of a clinical trial with anti-CTLA-4 and anti-PD-L1 immunotherapies in metastatic breast cancer using a systems pharmacology model.
- Hanwen Wang (Contributor)
- Oleg Milberg (Contributor)
- Imke H. Bartelink (Contributor)
- Paolo Vicini (Contributor)
- Bing Wang (Contributor)
- Rajesh Narwal (Contributor)
- Lorin Roskos (Contributor)
- Cesar A. Santa-Maria (Contributor)
- Aleksander S. Popel (Contributor)
Dataset